Filing Details
- Accession Number:
- 0000711377-21-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-05 18:36:00
- Reporting Period:
- 2021-03-31
- Accepted Time:
- 2021-04-05 18:36:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1188987 | A Terri Morrical | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-31 | 7,401 | $40.46 | 44,976 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-31 | 24,000 | $60.43 | 68,976 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-31 | 31,401 | $88.03 | 37,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2021-03-31 | 7,401 | $0.00 | 7,401 | $40.46 |
| Common Stock | Common Stock (Right to Buy) | Disposition | 2021-03-31 | 24,000 | $0.00 | 24,000 | $60.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 114,000 | 2021-10-29 | No | 4 | M | Direct | |
| 90,000 | 2022-11-27 | No | 4 | M | Direct |
Footnotes
- Options were granted on 9/29/2016, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant
- Options were granted on 10/27/2017, have five year lives, and vest in equal annual 20% installments on ech of the first five anniversary dates of the grant
Billionaire Hedge Funds
